跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
普拉曲沙注射液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Pralatrexate Injection
Approved
化学药品
Pralatrexate Injection
IDEOGEN AG
🇨🇳 National Medical Products Administration
Approval Date
Aug 26, 2020
Approval ID
81u8kAfEmZH
Company
IDEOGEN AG
Type
化学药品
Approval Details
Approval Id
81u8kAfEmZH
Approval Number
国药准字HJ20200031
Generic Name
普拉曲沙注射液
Generic Name En
Pralatrexate Injection
Drug Type
化学药品
Dosage Form
注射剂
Strength
1ml:20mg
Reg Date
2020-08-26
Expired Date
2025-08-25
Company Name
IDEOGEN AG
Company Address
Hurdnerstrasse 119, 8640 Hurden/SZ, Switzerland
Production Company Name
Baxter Oncology GmbH
Production Company Address
Kantstraβe 2, 33790 Halle/Westfalen, Germany
Company Detail Path
/organization/ideogen-ag
Production Company Detail Path
/organization/baxter-oncology-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 26, 2020
Approval ID
81u8kAfEmZH
Type
化学药品
Back to NMPA Approvals